Cytodyn Inc (CYDY)

[LongTkt]

Party at IncellDX!

When a new shipment of clinical trial blood draws are received, BP probably shuts all the lights off and fires up a giant black light in his lab to see which samples glow Leronlimab vs unreactive placebo. No wonder he's so confident about Leronlimab and NP is all smiles. Do you think BP has a few Greatful Dead tour posters hanging in his lab?

If the sample glows and the RANTS are low then the the clinical trial is going well. If the sample doesn't glow and the RANTS are high, then it is a Day 0 sample OR its from the placebo group - both without Leronlimab. More anecdotal evidence.

I suppose it is no different than measuring low RANTS in a sample. The blood samples from participants must be simply labeled with an ID number and no other identifying information to make it harder for BP/NP to unmask the trial data early.